QHP Capital Acquires Principal IRB and Rebrands It as Univo IRB

February 21, 2024

QHP Capital has acquired Principal IRB and relaunched the business as Univo IRB, a next-generation institutional review board focused on agile IRB review services for clinical trials. The investment positions QHP to build and scale a tech-enabled life sciences services platform, leveraging Univo's accredited IRB team and industry-focused technologies to support sponsors, CROs, and device companies.

Buyers
QHP Capital
Targets
Univo IRB (formerly Principal IRB)
Location
North Carolina, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.